JACQUELINE PEVNY: Open Payments
NPI 1114098431 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 13 payments from 7 companies in 2025. Trend: 2023 $495 · 2024 $199 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $160 |
| Vanda Pharmaceuticals Inc. | 2 | $141 |
| Supernus Pharmaceuticals, Inc. | 1 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| Indivior Inc. | 1 | $34 |
Products named: COBENFY, FANAPT, Qelbree, CAPLYTA, REXULTI, SUBLOCADE, SPRAVATO, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
